|
ORIC Pharmaceuticals, Inc. (ORIC) Avaliação DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
ORIC Pharmaceuticals, Inc. (ORIC) Bundle
Obtenha informações sobre sua análise de avaliação Oric Pharmaceuticals, Inc. (ORIC) usando nossa sofisticada calculadora DCF! Este modelo do Excel é pré -carregado com dados ORIC reais, permitindo que você ajuste as previsões e suposições para determinar com precisão o valor intrínseco da ORIC Pharmaceuticals, Inc. (ORIC).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -74.2 | -78.0 | -91.8 | -109.7 | -142.9 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 1.0 | .9 | 1.0 | 1.0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -75.2 | -78.9 | -92.7 | -110.8 | -142.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 293.6 | 237.0 | 206.3 | 208.2 | 256.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .8 | 1.9 | 1.3 | .9 | 1.5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.7 | -.9 | -2.1 | -.8 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -99.2 | -77.8 | -95.2 | -110.8 | -142.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -98.1 | -76.7 | -96.9 | -111.0 | -142.3 | -1.5 | .0 | .0 | .0 | .0 |
| WACC, % | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 | 9.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -59 | |||||||||
| Equity Value | 58 | |||||||||
| Diluted Shares Outstanding, MM | 70 | |||||||||
| Equity Value Per Share | 0.83 |
What You Will Get
- Real ORIC Financial Data: Pre-filled with ORIC Pharmaceuticals’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See ORIC’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Clinical Parameters: Adjust key inputs such as trial phases, patient enrollment rates, and treatment efficacy.
- Instant Valuation Metrics: Quickly computes intrinsic value, NPV, and other financial indicators.
- High-Precision Analytics: Leverages ORIC Pharmaceuticals’ actual financial data for accurate valuation results.
- Streamlined Scenario Testing: Easily evaluate various assumptions and assess different outcomes.
- Efficiency Booster: Remove the complexity of creating intricate valuation models from the ground up.
How It Works
- 1. Download the Template: Obtain and open the Excel file containing ORIC Pharmaceuticals, Inc. (ORIC) preloaded data.
- 2. Modify Assumptions: Adjust critical inputs such as growth projections, WACC, and capital expenditures.
- 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to investigate different valuation possibilities.
- 5. Present with Assurance: Deliver professional valuation insights to reinforce your strategic decisions.
Why Choose This Calculator for ORIC Pharmaceuticals, Inc. (ORIC)?
- Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and investors.
- Comprehensive Data: ORIC's historical and projected financials are preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Insightful Results: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Detailed step-by-step instructions make navigation simple.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment related to ORIC Pharmaceuticals, Inc. (ORIC).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding ORIC.
- Consultants and Advisors: Deliver clients precise valuation insights for ORIC Pharmaceuticals, Inc. (ORIC) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling with a focus on ORIC.
- Biotech Enthusiasts: Gain insights into how biotechnology companies like ORIC Pharmaceuticals, Inc. (ORIC) are valued in the market.
What the Template Contains
- Pre-Filled Data: Includes ORIC Pharmaceuticals' historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze ORIC Pharmaceuticals' profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.